These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 5550376)

  • 1. Fecal chymotrypsin and trypsin determinations.
    Smith JS; Ediss I; Mullinger MA; Bogoch A
    Can Med Assoc J; 1971 Apr; 104(8):691-4 passim. PubMed ID: 5550376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of chymotrypsin in the stool in chronic pancreatic diseases associated with exocrine insufficiency].
    Wegmann R; Krauter S; Löffelmann K
    Wien Med Wochenschr; 1976 Mar; 126(13-14):181-6. PubMed ID: 983089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Critical studies on the diagnostic significance of chymotrypsin determination in pancreatic diseases].
    Brügmann E; Rohde L; Töwe J; Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):223-5. PubMed ID: 4792422
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of chymotrypsin in the stool by succinyl-L-phenylalanin-P-nitraniliden (Suphepa) in the diagnosis of pancreatic diseases (author's transl)].
    Löffler A; Ernst R; Miederer SE; Stadelmann O
    Med Klin; 1975 Oct; 70(43):1755-8. PubMed ID: 1186580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Faecal enzyme diagnostic (author's transl)].
    Müller G
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(6):257-65. PubMed ID: 94852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of fecal trypsin and chymotrypsin as screening method for exocrine pancreas insufficiency].
    Schneider R; Dürr HK; Bode JC
    Verh Dtsch Ges Inn Med; 1973; 79():859-61. PubMed ID: 4790024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of fecal chymotrypsin. Clinical and methodological aspects (author's transl)].
    Bornschein W
    Leber Magen Darm; 1977 Oct; 7(5):334-40. PubMed ID: 926984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests.
    Lami F; Callegari C; Miglioli M; Barbara L
    Am J Gastroenterol; 1984 Sep; 79(9):697-700. PubMed ID: 6332529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of fecal chymotrypsin as a screening test for exocrine pancreatic insufficiency: studies on the reliability of various methods].
    Schneider R; Dürr HK; Bode JC
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():952-4. PubMed ID: 1029330
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the proteolytic activity of feces in pancreatic diseases.
    Halawa B; Swiderska T
    Pol Med J; 1970; 9(2):349-53. PubMed ID: 5422804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Measurement of fecal elastase 1 by immunoreactivity: a new indirect test of the pancreatic function].
    Stein J; Schoonbroodt D; Jung M; Lembcke B; Caspary WF
    Gastroenterol Clin Biol; 1996; 20(5):424-9. PubMed ID: 8761139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of pancreatic function. Determination of fecal chymotrypsin and the secretin-pancreozymin test. Comparative study].
    Tympner F; Reiner T; Domschke W
    Fortschr Med; 1977 Jul; 95(27):1711-4. PubMed ID: 903053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypsin and chymotrypsin as aids in the diagnosis of pancreatic disease.
    Goldberg DM; Sale JK; Fawcett N; Wormsley KG
    Am J Dig Dis; 1972 Sep; 17(9):780-92. PubMed ID: 5056859
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal chymotrypsin and elastase-1 determination on one single stool collected at random: diagnostic value for exocrine pancreatic status.
    Molinari I; Souare K; Lamireau T; Fayon M; Lemieux C; Cassaigne A; Montaudon D
    Clin Biochem; 2004 Sep; 37(9):758-63. PubMed ID: 15329313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of chymotrypsin in the feces by a new photometric method].
    Dockter G; Hoppe-Seyler F; Appel W; Sitzmann FC
    Padiatr Padol; 1985; 20(3):257-65. PubMed ID: 4034216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of fecal chymotrypsin and trypsin assessment for detection of pancreatic disease. A comparative study.
    Ammann RW; Tagwecher E; Kashiwagi H; Rosenmund H
    Am J Dig Dis; 1968 Feb; 13(2):123-46. PubMed ID: 5635854
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of exocrine pancreatic insufficiency in cirrhotic patients,using the fecal chymotrypsin test].
    Grassi M; Lazzari S; Palmisano P; Nocchi S; Fontana M; Raffa S; Antonelli M
    Clin Ter; 1994 Jun; 144(6):501-9. PubMed ID: 8001334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the determination of trypsin and chymotrypsin activity in the feces of dogs and their significance in the diagnosis of chronic exocrine pancreatic insufficiency].
    Freudiger U; Berger G
    Schweiz Arch Tierheilkd; 1971 Apr; 113(4):169-83. PubMed ID: 5103641
    [No Abstract]   [Full Text] [Related]  

  • 19. Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults.
    Brydon WG; Kingstone K; Ghosh S
    Ann Clin Biochem; 2004 Jan; 41(Pt 1):78-81. PubMed ID: 14713391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal chymotroypsin: a study on its diagnostic value by comparison with the secretin-cholecystokinin test.
    Dürr HK; Otte M; Forell MM; Bode JC
    Digestion; 1978; 17(5):404-9. PubMed ID: 680417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.